Ignite Creation Date:
2025-12-24 @ 9:59 PM
Ignite Modification Date:
2025-12-25 @ 7:36 PM
Study NCT ID:
NCT03267732
Status:
COMPLETED
Last Update Posted:
2019-04-05
First Post:
2017-08-24
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Study to Evaluate the Pharmacokinetics in Participants After Dosing With Pegilodecakin (LY3500518)
Sponsor:
Eli Lilly and Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-09-05
Start Date Type:
ACTUAL
Primary Completion Date:
2017-10-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-10-30
Completion Date Type:
ACTUAL
First Submit Date:
2017-08-24
First Submit QC Date:
None
Study First Post Date:
2017-08-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-04-03
Last Update Post Date:
2019-04-05
Last Update Post Date Type:
ACTUAL